Latest News
Swift Biosciences Releases Targeted S Gene Panel to Accelerate Surveillance of Emerging Strains of SARS-CoV-2
27 January 2021 - - US-based Swift Biosciences has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers, the company said.

The Swift Normalase Amplicon SARS-CoV-2 S Gene Panel elim...
Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of Xeljanz in Subjects with Rheumatoid Arthritis
27 January 2021 - - US-based pharmaceutical company Pfizer Inc. (NYSE: PFE) has released co-primary endpoint results from a recently completed post-marketing required safety study, ORAL Surveillance (A3921133; NCT02092467).

The primary ...
Moderna In Talks with US Government for Additional 100m Doses of the Moderna COVID-19 Vaccine
27 January 2021 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) is in discussion with the US government to purchase an additional 100m doses of the Moderna COVID-19 Vaccine for delivery in the third quarter of 2021, the company has co...
First Subjects Dosed in Phase 1 Trial of CORVax12, OncoSec's COVID-19 Vaccine Candidate Combining Interleukin-12 (IL-12) with an Enhanced SARS-CoV-2 Spike Protein
27 January 2021 - - US-based biotechnology company OncoSec Medical Inc. (NASDAQ: ONCS) has dosed several subjects in its Phase 1 clinical trial of CORVax12, the only vaccine candidate to include an immunostimulatory...
Kryon V-Bot Automates Large-Scale Scheduling of COVID-19 Vaccinations
27 January 2021 - - US-based automation solution provider Kryon has launched its new, off-the-shelf bot, V-Bot, worldwide, the company said.

This software bot accelerates and streamlines the scheduling of hundreds of thousands of patient...